Resources

Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.

Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.

Updates on operational research for lymphatic filariasis were shared from the Neglected Tropical Diseases Support Center on January 16, 2020.

The Carter Center's Emily Griswold presents on improving mass drug administration tools on January 16, 2020.

RTI's Clara Burgert and Diana Lu talk about how to ensure high-quality standardized surveys on January 16, 2020.

RTI's Clara Burgert leads a panel discussion on how to investigate and respond to LF survey failures on January 15, 2020.

IMA World Health's Abdel Direny, MD, MPH, presented guidance for transmission assessment survey preparation and supervision on January 15, 2020.

The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip irregularity reporting in a bilingual presentation, titled "rapportage de irrégularités de FTS" in French, on January 14, 2020.

The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip quality as a diagnostic tool and reporting issues with the tool on January 14, 2020.

USAID's Emily Toubali provided an overview of the NTD Division's work on lymphatic filariasis on January 14, 2020